Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics Indian Medical PG Practice Questions and MCQs

Question 11: All of the following drugs have poor penetration into the brain and eyes except?

A. Glycopyrrolate
B. Pilocarpine (Correct Answer)
C. Tiotropium bromide
D. Isopropamide

Explanation: ### Explanation The penetration of a drug into the brain (Blood-Brain Barrier) and the eyes (Blood-Retinal Barrier) is primarily determined by its **chemical structure and lipid solubility**. **1. Why Pilocarpine is Correct:** Pilocarpine is a **tertiary ammonium compound**. Unlike quaternary compounds, tertiary amines are uncharged (non-ionized) at physiological pH, making them highly lipid-soluble. This allows them to easily cross lipid membranes, including the blood-brain barrier (BBB) and the corneal epithelium. Consequently, Pilocarpine can penetrate the eye and the CNS effectively. **2. Why the Other Options are Incorrect:** * **Glycopyrrolate, Tiotropium bromide, and Isopropamide** are all **quaternary ammonium compounds**. * These molecules carry a permanent positive charge (ionized), which makes them highly water-soluble (hydrophilic) but lipid-insoluble. * Because they are ionized, they cannot cross the BBB or penetrate the ocular barriers effectively. This is why Glycopyrrolate is preferred over Atropine (a tertiary amine) when CNS side effects need to be avoided during anesthesia. **3. High-Yield NEET-PG Pearls:** * **Tertiary Amines (Cross BBB):** Atropine, Physostigmine, Pilocarpine, Scopolamine. * **Quaternary Amines (Do NOT cross BBB):** Neostigmine, Pyridostigmine, Glycopyrrolate, Ipratropium, Tiotropium. * **Clinical Application:** Physostigmine (tertiary) is the antidote for Atropine poisoning because it can enter the CNS to reverse central anticholinergic symptoms, whereas Neostigmine (quaternary) cannot. * **Mnemonic:** "Quaternary stays in the Quarry" (stays outside the brain/eye).

Question 12: Which of the following is an example of learned tolerance?

A. Avoiding alcohol when feeling unsteady
B. Drinking alcohol only with food
C. Walking a straight line when intoxicated (Correct Answer)
D. Not driving when drunk

Explanation: **Explanation:** **Learned Tolerance** (also known as behavioral tolerance) refers to a reduction in the effects of a drug that results from compensatory mechanisms learned by the individual through experience. It occurs when a person performs a task repeatedly while under the influence of a drug, eventually learning to function effectively despite the impairment. **Why Option C is Correct:** Walking a straight line while intoxicated is the classic example of learned tolerance. An individual who frequently consumes alcohol learns to consciously coordinate their motor movements and utilize visual cues to compensate for the cerebellar ataxia and vestibular impairment caused by ethanol. This is a behavioral adaptation rather than a change in drug metabolism or receptor sensitivity. **Analysis of Incorrect Options:** * **Options A, B, and D** represent **behavioral modifications** or safety strategies. Avoiding alcohol when unsteady, eating food to slow absorption (pharmacokinetic intervention), or choosing not to drive are conscious decisions to mitigate risk, but they do not involve the physiological or psychological "learning" to overcome a drug-induced deficit while the drug is active in the system. **High-Yield NEET-PG Pearls:** 1. **Pharmacodynamic Tolerance:** Occurs due to adaptive changes in the biological system (e.g., down-regulation of receptors like GABA receptors in chronic benzodiazepine use). 2. **Pharmacokinetic (Metabolic) Tolerance:** Occurs when the drug induces its own metabolism (e.g., Carbamazepine or Phenobarbitone inducing Cytochrome P450 enzymes). 3. **Tachyphylaxis:** A form of acute tolerance where drug effects diminish rapidly after only a few doses (e.g., Ephedrine, Tyramine, Nitroglycerin). 4. **Reverse Tolerance (Sensitization):** An increase in response to the same dose of a drug with repeated use (e.g., Cocaine-induced seizures).

Question 13: Aspirin in low doses produces long-lasting inhibition of platelet cyclooxygenase because:

A. Platelets contain a low quantity of COX.
B. Platelets cannot synthesize fresh COX molecules. (Correct Answer)
C. Platelets bind aspirin with high affinity.
D. Platelet COX is inducible.

Explanation: **Explanation:** The correct answer is **B. Platelets cannot synthesize fresh COX molecules.** **Mechanism of Action:** Aspirin (Acetylsalicylic acid) acts by **irreversibly** acetylating the serine residue at the active site of the Cyclooxygenase-1 (COX-1) enzyme. In most nucleated cells (like vascular endothelium), the cell can simply synthesize new COX enzymes to replace the inhibited ones. However, **platelets are anuclear** (lacking a nucleus); they lack the genetic machinery to perform protein synthesis. Once aspirin inhibits the COX-1 enzyme in a platelet, that specific platelet is incapacitated for the remainder of its lifespan (approximately 7–10 days). This explains why even low doses of aspirin have a prolonged antiplatelet effect. **Analysis of Incorrect Options:** * **A: Platelets contain a low quantity of COX:** While the amount of COX is finite, the duration of action is determined by the *irreversibility* of the bond and the lack of regeneration, not the initial quantity. * **C: Platelets bind aspirin with high affinity:** Aspirin does not necessarily have a higher affinity for platelet COX compared to other tissues; the distinction lies in the platelet's inability to recover from the covalent bond. * **D: Platelet COX is inducible:** COX-1 is a constitutive enzyme. COX-2 is the "inducible" isoform typically associated with inflammation. Platelet function is primarily mediated by constitutive COX-1. **High-Yield NEET-PG Pearls:** * **Low-dose Aspirin (75–150 mg):** Selectively inhibits Thromboxane A2 (TXA2) in platelets without significantly affecting Prostacyclin (PGI2) in the endothelium. * **Zero-order kinetics:** Aspirin follows first-order kinetics at low doses but shifts to zero-order kinetics at high/toxic doses (Salicylism). * **Surgery Prep:** Aspirin should ideally be stopped **7 days** prior to elective surgery to allow for the generation of a new population of functional platelets.

Question 14: Sodium thiopental is ultra-short acting due to –

A. Rapid absorption
B. Rapid metabolism
C. Rapid redistribution (Correct Answer)
D. Rapid excretion

Explanation: **Explanation:** **1. Why "Rapid Redistribution" is correct:** Sodium thiopental is a highly lipid-soluble barbiturate. When administered intravenously, it rapidly crosses the blood-brain barrier and reaches peak concentrations in the brain (a highly perfused organ) within seconds, causing immediate anesthesia. However, its action lasts only 5–10 minutes. This short duration is not due to metabolism, but because the drug quickly moves out of the brain and "redistributes" into less-perfused tissues like skeletal muscle and eventually adipose tissue. As the plasma concentration falls during this redistribution phase, the drug leaves the brain to maintain equilibrium, leading to a rapid termination of its anesthetic effect. **2. Why other options are incorrect:** * **Rapid absorption:** Absorption refers to the entry of a drug into the bloodstream. Since thiopental is given intravenously, it bypasses the absorption phase entirely (100% bioavailability). * **Rapid metabolism:** Thiopental is metabolized in the liver, but this process is relatively slow (~10–12% per hour). Metabolism is responsible for the ultimate elimination of the drug, not the immediate recovery from anesthesia. * **Rapid excretion:** Thiopental is excreted by the kidneys only after being metabolized into water-soluble metabolites. Renal excretion does not determine the initial duration of action. **3. High-Yield Clinical Pearls for NEET-PG:** * **Context-Sensitive Half-life:** While a single dose is short-acting due to redistribution, repeated doses or continuous infusion lead to "saturation" of peripheral tissues. This causes the drug to accumulate, significantly prolonging recovery time. * **Adverse Effect:** Thiopental can cause **laryngospasm** (it does not suppress laryngeal reflexes well) and potent respiratory depression. * **Contraindication:** It is strictly contraindicated in **Acute Intermittent Porphyria** as it induces ALA synthase. * **pH Sensitivity:** It is highly alkaline; accidental intra-arterial injection can cause severe spasm and gangrene (treated with vasodilator like Papaverine or Heparin).

Question 15: Methemoglobinemia is a known complication following the administration of which of the following drugs?

A. Lignocaine
B. Lidocaine
C. Prilocaine (Correct Answer)
D. Procaine

Explanation: **Explanation:** **Prilocaine** is the correct answer because of its unique metabolic pathway. It is an amide-linked local anesthetic that is metabolized in the liver into **o-toluidine**. This specific metabolite is an oxidizing agent that converts ferrous iron ($Fe^{2+}$) in hemoglobin to ferric iron ($Fe^{3+}$), resulting in the formation of **methemoglobin**. Methemoglobin cannot effectively bind or transport oxygen, leading to tissue hypoxia and characteristic "chocolate-colored blood" or cyanosis that does not improve with oxygen therapy. **Analysis of Options:** * **Lignocaine & Lidocaine (Options A & B):** These are the same drug. While lidocaine is the most commonly used local anesthetic, it does not typically cause methemoglobinemia at standard doses. (Note: In rare cases of extreme toxicity, its metabolite *monoethylglycinexylidide* might contribute, but it is not the classic association). * **Procaine (Option D):** This is an ester-linked local anesthetic. It is rapidly hydrolyzed by plasma pseudocholinesterase into para-aminobenzoic acid (PABA), which is associated with allergic reactions rather than methemoglobinemia. **High-Yield Clinical Pearls for NEET-PG:** * **Other causative agents:** Benzocaine (topical spray), Nitrites/Nitrates, Dapsone, and Sulfonamides. * **Clinical Presentation:** Cyanosis with a "normal" $PaO_2$ on ABG but low $SpO_2$ (the "Saturation Gap"). * **Treatment of Choice:** **Methylene Blue** (1-2 mg/kg IV). It acts as a reducing agent to restore iron to its $Fe^{2+}$ state. * **Alternative Treatment:** Vitamin C (Ascorbic acid) can be used if Methylene Blue is contraindicated (e.g., in G6PD deficiency).

Question 16: Which of the following drugs can be administered subdermally?

A. Nicotine
B. Fentanyl
C. Glyceryl trinitrate (GTN)
D. Progesterone (Correct Answer)

Explanation: **Explanation:** The correct answer is **Progesterone**. **1. Why Progesterone is correct:** Subdermal administration involves the surgical implantation of a drug-containing capsule or pellet under the skin (usually the upper arm). This route is designed for **long-term, sustained release** of drugs over months or years. Progesterone (and its analogs like Etonogestrel) is highly lipid-soluble and effective in minute quantities, making it ideal for subdermal implants (e.g., **Nexplanon**). These implants provide effective contraception for up to 3 years by bypassing first-pass metabolism and ensuring steady plasma concentrations. **2. Why the other options are incorrect:** * **Nicotine, Fentanyl, and Glyceryl trinitrate (GTN):** These drugs are typically administered via the **Transdermal (Patch)** route, not subdermal. * **Transdermal route:** Drug is applied to the surface of intact skin and absorbed into the systemic circulation through the dermis. It is non-invasive. * **Subdermal route:** Requires a minor surgical incision for implantation. **3. High-Yield Clinical Pearls for NEET-PG:** * **Subdermal Implants:** Common examples include **Norplant** (Levonorgestrel) and **Nexplanon**. * **Pellet Implantation:** Another form of subdermal delivery used for Testosterone and Estradiol. * **Transdermal Patches:** Preferred for drugs with high first-pass metabolism and short half-lives. Common examples: **Scopolamine** (motion sickness), **Nitroglycerin** (angina), **Fentanyl** (chronic pain), and **Nicotine** (smoking cessation). * **Key Advantage:** Both routes bypass the "First-pass effect," increasing bioavailability.

Question 17: When one drug decreases or inhibits the action of another, it is called:

A. Antagonism (Correct Answer)
B. Agonism
C. Inverse agonism
D. Synergism

Explanation: Antagonism is the pharmacological phenomenon where one drug (the antagonist) opposes or inhibits the action of another drug (the agonist) or an endogenous ligand [2]. This occurs when the antagonist binds to the receptor but does not trigger a biological response (it has **affinity but zero intrinsic activity**). By occupying the receptor site, it prevents the agonist from binding, thereby decreasing its effect [1]. **2. Why Other Options are Incorrect:** * **Agonism:** This refers to a drug that binds to a receptor and activates it to produce a maximal biological response (e.g., Adrenaline at $\beta_1$ receptors) [3]. * **Inverse Agonism:** These drugs bind to the same receptor as an agonist but produce a response that is **physiologically opposite** to that of the agonist. They possess negative intrinsic activity (e.g., DMCM at GABA receptors). * **Synergism:** This is the opposite of antagonism. It occurs when the combined effect of two drugs is greater than the sum of their individual effects ($1+1 > 2$), such as Levodopa + Carbidopa. **3. NEET-PG Clinical Pearls:** * **Competitive Antagonism:** The dose-response curve shifts to the **right** (potency decreases, but maximal efficacy remains the same) [2]. Example: Atropine vs. Acetylcholine. * **Non-competitive Antagonism:** The dose-response curve shifts **downwards** (maximal efficacy decreases). Example: Phenoxybenzamine vs. Adrenaline. * **Chemical Antagonism:** Occurs when two drugs react chemically in solution (e.g., Heparin neutralized by Protamine sulfate). * **Physiological Antagonism:** Two drugs act on different receptors to produce opposite effects on the same system (e.g., Glucagon and Insulin on blood glucose).

Question 18: What percentage of a drug remains in the body after 3 half-lives?

A. 12.50% (Correct Answer)
B. 75%
C. 87.50%
D. 94%

Explanation: **Explanation:** The concept tested here is the **elimination kinetics** of a drug, specifically focusing on the **half-life ($t_{1/2}$)**. The half-life is the time required for the plasma concentration of a drug to be reduced by 50%. **Why 12.50% is Correct:** In first-order kinetics (followed by most drugs), a constant fraction of the drug is eliminated per unit of time. The percentage of the drug remaining follows a predictable decay pattern: * **0 Half-life:** 100% remains. * **1 Half-life:** 50% remains (50% eliminated). * **2 Half-lives:** 25% remains (50% of 50%; 75% eliminated). * **3 Half-lives:** **12.50% remains** (50% of 25%; 87.5% eliminated). **Analysis of Incorrect Options:** * **B (75%):** This represents the amount **eliminated** after 2 half-lives, not the amount remaining after 3. * **C (87.50%):** This is the total percentage of the drug **eliminated/cleared** from the body after 3 half-lives ($100 - 12.5 = 87.5$). * **D (94%):** This is the approximate percentage of the drug **eliminated** after 4 half-lives ($100 - 6.25 = 93.75$). **NEET-PG High-Yield Pearls:** 1. **Steady State:** It takes approximately **4 to 5 half-lives** for a drug to reach steady-state concentration ($C_{ss}$) during constant-rate infusion. 2. **Complete Elimination:** For clinical purposes, a drug is considered "completely" eliminated from the body after **5 half-lives** (96.8% cleared). 3. **First-order vs. Zero-order:** In first-order kinetics, $t_{1/2}$ is constant. In zero-order kinetics (e.g., high-dose Aspirin, Phenytoin, Ethanol), a constant *amount* is eliminated, and $t_{1/2}$ is not constant. 4. **Formula:** Percentage remaining = $(1/2)^n \times 100$, where $n$ is the number of half-lives.

Question 19: Titration of drug dosage based on patient response is most effectively achieved with which of the following routes of administration?

A. Sublingual
B. Transdermal
C. Inhalation (Correct Answer)
D. Subcutaneous

Explanation: **Explanation:** The core concept behind effective dose titration is the **rapidity of onset** and the **ability to terminate drug delivery** once the desired effect is achieved. **Why Inhalation is Correct:** The inhalation route offers a very large surface area (alveolar membrane) and high vascularity, leading to an almost instantaneous onset of action, similar to intravenous administration. More importantly, it allows for **breath-by-breath titration**. In clinical practice (e.g., volatile anesthetics like Sevoflurane), the clinician can increase or decrease the concentration of the drug in the inspired air and see an immediate change in the patient's physiological state. If an adverse effect occurs, stopping the inhalation leads to rapid elimination of the drug from the lungs. **Why Other Options are Incorrect:** * **Sublingual:** While it bypasses first-pass metabolism and has a quick onset (e.g., Nitroglycerin), once the tablet is dissolved, the dose cannot be "titrated" or withdrawn to fine-tune the response. * **Transdermal:** This route is designed for **slow, sustained release** (e.g., Fentanyl patches). It has a very long lag time to reach steady-state plasma levels, making it the least suitable for acute titration. * **Subcutaneous:** Absorption is relatively slow and depends on local blood flow. Once injected, the drug depot cannot be removed, preventing precise control over the immediate response. **High-Yield Clinical Pearls for NEET-PG:** * **Inhalation** is the fastest route for drugs to reach the brain (shorter path than IV). * **Bioavailability** of IV route is 100% by definition. * **First-pass metabolism** is bypassed by Sublingual, Transdermal, and Inhalation routes, but only partially bypassed by the Rectal route (approx. 50%).

Question 20: What does the clearance of a drug refer to?

A. The efficacy of elimination of a drug by an organ or the whole body.
B. It cannot be greater than the blood flow to an organ.
C. It determines the steady-state drug concentration.
D. All the above. (Correct Answer)

Explanation: **Clearance (Cl)** is one of the most critical pharmacokinetic parameters in clinical practice. It represents the theoretical volume of plasma from which a drug is completely removed per unit of time (e.g., mL/min) [1]. 1. **Why Option A is correct:** Clearance is the quantitative measure of the body's efficiency in eliminating a drug. It is the sum of all elimination processes (Renal + Hepatic + Others). Mathematically, $Cl = ext{Rate of elimination} / ext{Plasma concentration}$ [2]. 2. **Why Option B is correct:** An organ cannot remove more drug than is delivered to it via blood. Therefore, the clearance of a drug by a specific organ (like the liver) can never exceed the blood flow to that organ ($Q$) [1]. For example, hepatic clearance cannot exceed hepatic blood flow (~1500 mL/min). 3. **Why Option C is correct:** This is a high-yield clinical concept. At steady state, the rate of drug administration equals the rate of elimination. The formula $Css = ext{Infusion rate} / Cl$ shows that clearance is the primary determinant of the **Steady-State Concentration ($C_{ss}$)** [1]. **Clinical Pearls for NEET-PG:** * **Maintenance Dose:** Clearance is the parameter used to calculate the maintenance dose ($MD = C_{ss} imes Cl$) [1]. * **Half-life ($t_{1/2}$):** Clearance is inversely proportional to half-life ($t_{1/2} = 0.693 imes Vd / Cl$). If clearance decreases (e.g., renal failure), the half-life increases. * **First-order Kinetics:** For most drugs, clearance remains constant regardless of the plasma concentration [2]. * **Zero-order Kinetics:** Clearance decreases as the plasma concentration increases (e.g., Phenytoin, Alcohol, Salicylates at high doses) [2].

Practice by Chapter

Absorption and Bioavailability

Practice Questions

Drug Distribution and Protein Binding

Practice Questions

Biotransformation and Metabolism Pathways

Practice Questions

Renal and Non-renal Excretion

Practice Questions

Compartment Models

Practice Questions

Dose-Response Relationships

Practice Questions

Drug Efficacy and Potency

Practice Questions

Drug Tolerance and Tachyphylaxis

Practice Questions

Population Pharmacokinetics

Practice Questions

Pharmacokinetic Variability

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free